The specialty pharmacy received accreditation with zero deficiencies after a rigorous review

FORT MYERS, Fla., Jan. 30, 2023 (GLOBE NEWSWIRE) — The American Oncology Network, LLC (AON) in-house specialty pharmacy received re-accreditation with zero deficiencies through URAC

A Commitment to Excellence

The American Oncology Network’s in-house specialty pharmacy has once again proven its dedication to quality care and improved processes by receiving re-accreditation with zero deficiencies through URAC. This accreditation is a testament to the pharmacy’s commitment to providing the highest level of care to its patients.

What Does This Mean for Patients?

For patients, this re-accreditation means they can continue to trust the American Oncology Network’s specialty pharmacy to provide them with the highest quality medications and care. Knowing that the pharmacy has undergone a rigorous review and received zero deficiencies instills confidence in the services they provide.

Implications for the World

On a larger scale, the re-accreditation of the American Oncology Network’s in-house specialty pharmacy with zero deficiencies has a ripple effect. It sets a benchmark for other pharmacies, encouraging them to strive for excellence in their own practices. This commitment to quality care ultimately benefits patients worldwide, as it raises the standard of care across the industry.

Conclusion

The re-accreditation of the American Oncology Network’s in-house specialty pharmacy with zero deficiencies is a testament to their unwavering commitment to excellence. This achievement not only benefits patients who rely on their services but also sets a standard for pharmacies around the world to aspire to. By prioritizing quality care and improved processes, the pharmacy is making a positive impact on the industry as a whole.